MLICM
RXST icon

Metropolitan Life Insurance Company (MetLife)’s RxSight RXST Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,500
Closed -$77.4K – 1716
2024
Q1 		$77.4K Sell
1,500
-140
-9% -$6.87K ﹤0.01% 1192
2023
Q4 		$66.1K Buy
1,640
+101
+7% +$2.96K ﹤0.01% 1298
2023
Q3 		$42.9K Buy
1,539
+134
+10% +$4K ﹤0.01% 1495
2023
Q2 		$40.5K Hold
1,405
– – ﹤0.01% 1555
2023
Q1 		$23.4K Hold
1,405
– – ﹤0.01% 1799
2022
Q4 		$17.8K Hold
1,405
– – ﹤0.01% 2076
2022
Q3 		$16.9K Hold
1,405
– – ﹤0.01% 2103
2022
Q2 		$19.8K Buy
+1,405
New +$18.5K ﹤0.01% 2058

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RXST Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of RxSight (RXST) in Q2 2024, closing a stake of 1,500 shares — an estimated $77.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RXST in Q2 2022 and held it in 8 quarters. The position peaked at $77.4K in Q1 2024. 228 funds tracked by Wall St. Rank hold RXST as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining RxSight position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,500 RxSight shares in Q2 2024, an estimated $77.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in RxSight in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s RxSight position peaked at $77.4K in Q1 2024.
  • 228 funds tracked by Wall St. Rank held RxSight as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.